PofoliaShared via Pofolia

Journal of Periodontology· 2016Q1

Optimized Platelet‐Rich Fibrin With the Low‐Speed Concept: Growth Factor Release, Biocompatibility, and Cellular Response

Masako Fujioka‐Kobayashi, Richard J. Miron, Maria Hernandez, Umadevi Kandalam et al.

Short summary

Modifying platelet-rich fibrin (PRF) centrifugation speed and time with a low-speed concept (1,300 rpm) significantly increased growth factor release (PDGF, TGF-β1, EGF, IGF) and enhanced human fibroblast migration, proliferation, and collagen mRNA levels compared to standard PRF (2,700 rpm).

AI-generated from the title and abstract; the full text is not read.

Key points

  • Low-speed PRF centrifugation (1,300 rpm) significantly increased growth factor release (PDGF, TGF-β1, EGF, IGF) compared to standard PRF (2,700 rpm).
  • The A-PRF+ group (1,300 rpm, 8 minutes) showed the highest growth factor release.
  • Both A-PRF and A-PRF+ matrices enhanced human fibroblast migration and proliferation compared to standard L-PRF.
  • Gingival fibroblasts cultured with A-PRF+ showed increased mRNA levels for PDGF, TGF-β, and collagen1.

AI-generated from the title and abstract; the full text is not read.

Abstract

BACKGROUND: Over the past decade, use of leukocyte platelet-rich fibrin (L-PRF) has gained tremendous momentum in regenerative dentistry as a low-cost fibrin matrix used for tissue regeneration. This study characterizes how centrifugation speed (G-force) along with centrifugation time influence growth factor release from fibrin clots, as well as the cellular activity of gingival fibroblasts exposed to each PRF matrix. METHODS: Standard L-PRF served as a control (2,700 revolutions per minute [rpm]-12 minutes). Two test groups using low-speed (1,300 rpm-14 minutes, termed advanced PRF [A-PRF]) and low-speed + time (1,300 rpm-8 minutes; A-PRF+) were investigated. Each PRF matrix was tested for growth factor release up to 10 days (eight donor samples) as well as biocompatibility and cellular activity. RESULTS: The low-speed concept (A-PRF, A-PRF+) demonstrated a significant increase in growth factor release of platelet-derived growth factor (PDGF), transforming growth factor (TGF)-β1, epidermal growth factor, and insulin-like growth factor, with A-PRF+ being highest of all groups. Although all PRF formulations were extremely biocompatible due to their autogenous sources, both A-PRF and A-PRF+ demonstrated significantly higher levels of human fibroblast migration and proliferation compared with L-PRF. Furthermore, gingival fibroblasts cultured with A-PRF+ demonstrated significantly higher messenger RNA (mRNA) levels of PDGF, TGF-β, and collagen1 at either 3 or 7 days. CONCLUSIONS: The findings from the present study demonstrate modifications to centrifugation speed and time with the low-speed concept favor an increase in growth factor release from PRF clots. This, in turn, may directly influence tissue regeneration by increasing fibroblast migration, proliferation, and collagen mRNA levels. Future animal and clinical studies are now necessary.

The authors' abstract, as published at the source. Journal of Periodontology, 2016 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Urology

UrologyMedicine